30 participants
Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-04-01
- Start Date:
- 2024-03-11
- Completion:
- 2025-01-31
Conditions
- Cadonilimab and Lenvatinib
Interventions
- DRUG
No Results Yet